Hosted by the European Organisation for Research and Treatment of Cancer, the National Cancer Institute and the American Association for Cancer Research, the 2012 Symposium will bring together over 2,000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.

During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomised, multicentre cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information. For these reasons, the Symposium has been organised to ensure the maximum amount of interaction and discussion through an exciting range of plenary sessions and lively workshops.

Our host city is guaranteed to match the exciting promise of the Symposium itself. You can rest assured that at least one of the clichés about this city really is true: Dublin genuinely does have something for everyone. On the trail of the past you will find beautifully preserved mansions and castles, meticulously curated museums and magnificent churches, cathedrals and theatres. However, if you'd rather sample the very latest home-grown flavours from today's top chef or spend a few hours ambling through the parks and gardens, watch a hurling match, ride the DART out of town to Howth, Dalkey and Malahide or just sit on the Liffey boardwalk and let it all pass you by, you can do that too.